Published • loading... • Updated
Researchers test GLP-1 medications as possible treatment for opioid addiction
The double-blind study will enroll 31 adults and track whether the diabetes and obesity drugs reduce cravings and relapse during buprenorphine treatment.
Summary by WRTV
9 Articles
9 Articles
Researchers test GLP-1 medications as possible treatment for opioid addiction
GLP-1 receptor agonist drugs have long been used to treat diabetes and, more recently, obesity. Now, researchers are studying whether the medications could also help prevent opioid addiction relapse.Researchers at Vanderbilt University are launching a double-blind, randomized, placebo-controlled trial to determine whether GLP-1 medications can help treat opioid use disorder. Limited evidence has suggested the drugs may reduce opioid cravings.Res…
Coverage Details
Total News Sources9
Leaning Left0Leaning Right0Center9Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
